{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-21-053963","form_type":"8-K","ticker":"ADPT","cik":"0001478320","company_name":"Adaptive Biotechnologies Corp","filed_at":"2021-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.694911+00:00","generated_at":"2026-06-28T13:52:23.114292+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Adaptive Biotechnologies Q3 revenue up 50% to $39.5M, net loss widens; appoints new principal accounting officer","bullets":["Q3 2021 revenue $39.5M (+50% YoY); sequencing revenue $22.1M (+96%), development revenue $17.4M (+16%).","Net loss $56.0M vs $36.7M in Q3 2020; adjusted EBITDA loss $41.1M vs $28.4M.","Full-year 2021 revenue guidance reaffirmed at $148-155M, ~54% growth at midpoint.","clonoSEQ sequencing volume grew 47% YoY; launched enhanced assay for CLL including IGHV mutation status.","Kyle Piskel appointed principal accounting officer; Chad Cohen remains CFO and principal financial officer."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-21-053963","json":"https://secwatch.observer/filing/0001564590-21-053963.json","markdown":"https://secwatch.observer/filing/0001564590-21-053963.md","text":"https://secwatch.observer/filing/0001564590-21-053963.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1478320/000156459021053963/0001564590-21-053963-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1478320/000156459021053963/adpt-8k_20211028.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T13:52:23.114292+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"92c746e735","claim":"Kyle Piskel was appointed as principal accounting officer at Adaptive Biotechnologies Corp.","evidence_excerpt":"On October 28, 2021, the Board of Directors of the Company designated Kyle Piskel as the Company’s principal accounting officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1478320/000156459021053963/0001564590-21-053963-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"designated"},{"label":"Role","value":"principal accounting officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}